Hepatic Impairment clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • A Study of Seladelpar in Patients with Primary Biliary Cholangitis (PBC) and Abnormal Liver Function

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18-80

    The Effect of Hepatic Impairment on The Pharmacokinetics of Seladelpar: An Open-Label Study Following Oral Dosing of Seladelpar to Subjects with Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

    Sacramento, California and other locations

Last updated: